Compartmental Intrathecal Radioimmunotherapy: Results for Treatment for Metastatic CNS Neuroblastoma

Innovation in the management of brain metastases is needed. We evaluated the addition of compartmental intrathecal antibody-based radioimmunotherapy (cRIT) in patients with recurrent metastatic central nervous system (CNS) neuroblastoma following surgery, craniospinal irradiation, and chemotherapy....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kramer, Kim, Kushner, Brian H., Modak, Shakeel, Pandit-Taskar, Neeta, Smith-Jones, Peter, Zanzonico, Pat, Humm, John L., Xu, Hong, Wolden, Suzanne L., Souweidane, Mark M., Larson, Steven M., Cheung, Nai-Kong V.
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533371/
https://ncbi.nlm.nih.gov/pubmed/19890606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-0038-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires